GCEP must ensure balance, independence, objectivity, and scientific rigor in all their sponsored educational activities.  All faculty participating in a sponsored activity are expected to disclose to the activity audience any significant financial interest or other relationship (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity.  (Significant financial interest or other relationship can include such things as grants or research support, employee, consultant, major stockholder, member of the speaker’s bureau, etc.).  The intent of this disclosure is not to prevent a presenter with a significant financial or other relationship from making a presentation, but rather to provide listeners with information on which they can make their own judgments.  It remains for the audience to determine whether the speaker’s interests or relationships may influence the presentation.  In addition, presenters must make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices.

TERMS AND CONDITIONS

By signing the disclosure form, the speaker/author understands and accepts the following rules as required by ACEP (American College of Emergency Physicians), the Essential Areas and Policies of the ACCME, and the rules of the American Medical Association:

1. Disclosure. Speakers/authors must complete and submit a Disclosure Statement prior to the presentation, and that Disclosure Statement shall be complete and truthful to the best of the speaker’s knowledge.  Faculty are required to disclose any financial relationship they may have with any product or class of products they discuss in an educational activity.

2. Fair-Balance.  Speakers/Authors are required to prepare fair-and-balanced presentations, which are objective and scientifically rigorous. 

3. Unlabeled and Unapproved Uses.  Presentations that provide information in whole or in part related to non-FDA approved uses for drug products and/or devices must clearly acknowledge the unlabeled indications or the investigative nature of their proposed uses to the audience.  Speakers who plan to discuss non-FDA approved uses for commercial products and/or devices must advise the Accredited Provider of their intent.

4. Use of Generic versus Trade Names. Presenters should use scientific or generic names in referring to products in their lectures or enduring materials.  Should it be necessary to use a trade name, then the trade names of all similar products or those within a class should be used.

5. Commercial Supporter Influence. Faculty are not permitted to receive any direct remuneration or gifts from the commercial supporter(s) of this activity, nor should they be subject to direct input from a commercial supporter regarding the content of their presentation.

6. Any and all honoraria for this activity must be reported to ACEP.

PLEASE NOTE: AFFILIATIONS LISTED ON THE DISCLOSURE FORM MUST ALSO BE LISTED ON YOUR PRESENTATION, ON THE PAGE JUST AFTER THE TITLE PAGE, PER ACCREDITATION "FIRST SLIDE" POLICY.